about
Infection, inflammation and exercise in cystic fibrosisHematopoietic and mesenchymal stem cells for the treatment of chronic respiratory diseases: role of plasticity and heterogeneityImmunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosisAnti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosisAirway clearance techniques for cystic fibrosis: an overview of Cochrane systematic reviewsAnti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosisImmunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosisActive cycle of breathing technique for cystic fibrosisAnti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosisImmunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosisActive cycle of breathing technique for cystic fibrosisActive cycle of breathing technique for cystic fibrosisIdentification of the SPLUNC1 ENaC-inhibitory domain yields novel strategies to treat sodium hyperabsorption in cystic fibrosis airway epithelial culturesEpidemiology and differential diagnosis of nasal polypsDifferential epithelial expression of the putative innate immune molecule SPLUNC1 in cystic fibrosisA novel host defense system of airways is defective in cystic fibrosisDeterminants of mortality for adults with cystic fibrosis admitted in Intensive Care Unit: a multicenter studyActive cycle of breathing technique for cystic fibrosisEpithelial Anion Transport as Modulator of Chemokine SignalingCurrent and future treatment options for cystic fibrosis lung disease: latest evidence and clinical implicationsAnimal Models of Cystic Fibrosis Pathology: Phenotypic Parallels and DivergencesIslet-intrinsic effects of CFTR mutationAdvancing clinical development pathways for new CFTR modulators in cystic fibrosisPseudomonas Exotoxin A: optimized by evolution for effective killingMicroscale imaging of cilia-driven fluid flowLiver biopsy in modern clinical practice: a pediatric point-of-viewProgenitor cells in proximal airway epithelial development and regenerationTargeting mitochondrial dysfunction in lung diseases: emphasis on mitophagyCystic fibrosis chronic rhinosinusitis: a comprehensive reviewThe protein quality control machinery regulates its misassembled proteasome subunitsMethod for quantitative study of airway functional microanatomy using micro-optical coherence tomographyInhibition of myeloperoxidase: evaluation of 2H-indazoles and 1H-indazolones.A ferret model of COPD-related chronic bronchitis.A yeast phenomic model for the gene interaction network modulating CFTR-ΔF508 protein biogenesis.Origins of cystic fibrosis lung diseasePrecision Genomic Medicine in Cystic FibrosisUnderstanding the development of the respiratory glandsRegulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung DiseaseAngiotensin I-converting enzyme Gln1069Arg mutation impairs trafficking to the cell surface resulting in selective denaturation of the C-domainThe two-component system CprRS senses cationic peptides and triggers adaptive resistance in Pseudomonas aeruginosa independently of ParRS
P2860
Q21284416-F4A42A68-198D-4563-BC3C-0A1D8313BD78Q21284513-40A88917-82F0-44CD-BE16-F6D7E5209C2EQ24187829-56393A1A-C906-408D-933D-CDEFBC0D1E24Q24187980-732286F5-51E8-4A72-9786-FF7F39A11D4DQ24194690-E20B8C7B-9940-40CA-A6A1-1FB55D450EB0Q24198057-4ED4E2EA-5779-4656-A118-41169E27B9C9Q24201868-EAF5517F-2E55-43DC-AC77-65B4934F0E8CQ24202244-D4C888BA-5504-4BBD-ABF8-2E4F2BAD88E1Q24202662-03D508D4-9150-4634-BC34-41C51E21C06FQ24235470-36AE3C53-6F6E-412D-97FB-7284222546D7Q24236614-3CF028E6-8748-4C0D-80AE-875850052770Q24240423-897747A0-B1F2-4EDD-94E2-5CB1CE0A4454Q24338348-CF2A032B-9B21-4CBA-A15E-5D1335C05F7BQ24614953-66AA550B-0A7E-4CAA-B817-0C1C7204CB64Q24649836-13F757FE-1214-47C0-ACF7-A14F75F4FA4FQ24657774-02D66050-F108-4F0A-8A5A-F0218AC1EE29Q25257344-07B605C9-806A-4B5B-869F-CD4069902A22Q26471161-1F0D5D8D-C381-459E-82CF-8AC2027352A2Q26744381-38F7C62D-E9DD-4FDA-8E0F-11B07E8383EBQ26747065-89DF9921-22EB-41A9-808B-39299BE8D8A2Q26747210-D9959A4F-FB89-400C-BA07-F22328C6BC7FQ26749173-1A782B0D-30D7-4B95-9098-E6B043551767Q26768266-6D376675-62FC-47DC-8E90-F21D47488A39Q26781376-478252B6-0965-40F9-9DFE-BF8539905819Q26826635-073C8A18-422A-442F-AEF0-4FF2E817E541Q26826920-A84CDA3D-F826-4B8A-BBD7-0BCF89D5C53BQ26830118-8857641D-22AA-40FC-B207-BBBCE10F976DQ26992144-1EAD7AE3-19FA-486A-934E-AF765E92C473Q27003313-A3FF6E24-8A96-480F-8E97-5C95DA3FED6DQ27311236-BECB4B2F-8647-4870-A319-5BB1F9FFDC74Q27319331-3477312A-8387-4A31-A91F-6B77A440FE45Q27325561-AA77D055-6011-4143-BD60-5011E599146EQ27333635-BDD18134-69F1-4B1C-A650-C04A18DF0B1BQ27931694-93AB2354-EF75-4A89-AC83-36BE32AC4E18Q28080451-6D1E3E61-E0EE-4462-AC8A-918EB2005BE0Q28080906-88D7382D-E866-4738-AF1C-D750213FAFA8Q28081046-2FAC3340-003B-4615-B448-9DE852813BD5Q28391348-3D78FD20-81BE-41CA-BA33-10F727FD4EB5Q28473818-F641DD7C-078F-4BF9-B8CE-D0FFA3BDF506Q28492572-D0867F3A-1299-415C-86DD-6046D88956F5
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Cystic fibrosis
@ast
Cystic fibrosis
@en
Cystic fibrosis
@nl
type
label
Cystic fibrosis
@ast
Cystic fibrosis
@en
Cystic fibrosis
@nl
prefLabel
Cystic fibrosis
@ast
Cystic fibrosis
@en
Cystic fibrosis
@nl
P2093
P3181
P356
P1476
Cystic fibrosis
@en
P2093
Eric J Sorscher
Stacey Miller
Steven M Rowe
P304
P3181
P356
10.1056/NEJMRA043184
P407
P577
2005-05-12T00:00:00Z